China Shineway Pharmaceutical Group Limited
China Shineway Pharmaceutical Group Limited (CSWYF) Revenue
Annual & quarterly revenue history · segment & region breakdown
CSWYF · revenue · updated Jun 9, 2026
Core revenue metrics
Trailing 12 monthsChina Shineway Pharmaceutical Group Limited trailing twelve-month (TTM) revenue is $69.25B, a decrease of 17.01% year-over-year from $3.14B in FY2025.
Revenue trend
2025 – 2015 · AnnualRevenue history
| Fiscal year end | Revenue | Change | Growth |
|---|---|---|---|
| 2025-12-31 | $3.14B | -$0.64B | -17.01% |
| 2024-12-31 | $3.78B | -$28.22B | -88.19% |
| 2023-12-31 | $32.00B | +$27.97B | +694.01% |
| 2022-12-31 | $4.03B | +$0.86B | +27.06% |
| 2021-12-31 | $3.17B | +$0.66B | +26.28% |
| 2020-12-31 | $2.51B | -$0.20B | -7.45% |
| 2019-12-31 | $2.71B | +$0.04B | +1.51% |
| 2018-12-31 | $2.67B | +$0.81B | +43.30% |
| 2017-12-31 | $1.87B | -$0.22B | -10.64% |
| 2016-12-31 | $2.09B | -$0.03B | -1.61% |
Compare revenue vs peers
Drug Manufacturers - Specialty & GenericCompare CSWYF revenue against listed peers. Click any row to open that company's revenue tab.
About Revenue & Reporting
Revenue (also called sales, net sales, or turnover) is the total income China Shineway Pharmaceutical Group Limited receives from its business operations before deducting any costs or expenses. It is the top line of the income statement. Unlike net income or earnings, revenue does not account for operating costs, taxes, interest, or depreciation.
China Shineway Pharmaceutical Group Limited reports revenue on a fiscal year ending Dec 31 basis under US GAAP, denominated in CNY.
Data sourced from China Shineway Pharmaceutical Group Limited's 10-K and 10-Q SEC filings via Financial Modeling Prep.
Frequently asked questions
CSWYF revenue · 4 questionsCSWYF's trailing twelve-month (TTM) revenue is $69.25B. That is a decrease of 17.01% year-over-year from $3.14B in FY2025.
▸ Source: FMP · China Shineway Pharmaceutical Group Limited SEC filings · GAAP · China Shineway Pharmaceutical Group Limited SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 9, 2026